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and low proliferation [6] , ILC tumors paradoxically exhibit more frequent long-term recurrences 85 on endocrine therapy than IDC tumors [7, 8] . Furthermore, patients with ILC frequently present 86 with metastatic dissemination to unusual anatomical sites such as the peritoneum, ovaries and 87 gastrointestinal tract [1, 7] , clinical features that are not currently well understood. Kinase (FAK) [9, 10] . In the absence of such cell-matrix interactions, cells undergo detachment-92 induced cell death, which is termed anoikis [11] . As part of their evolution, some cancer cells 93 acquire an ability to survive in detached conditions, known as anoikis resistance [12] . This 94 anchorage-independence ability allows cells that have escaped from the site of the primary tumor 95 to survive in the blood stream and subsequently at foreign matrix environments at secondary 96 organs [13, 14] . As such, anoikis resistance is believed to be an important contributor to tumor 97 cell dissemination and a surrogate indicator of distant metastatic colonization ability [15, 16] . 
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Anchorage-independence has previously been described in mouse models of lobular cancer, 100 where combined somatic inactivation of p53 and E-cadherin induces metastatic ILC through 101 induction of anoikis resistance [17, 18] . Furthermore, loss of other adherens junction proteins 102 such as p120-catenin (p120) also induces metastatic progression of mouse ILC cells through 103 ROCK1-mediated anoikis resistance [19] [20] [21] (Figure 2A-D) . We confirmed these findings by 249 additional FACS analyses, which showed more CFSE-retaining IDC cells in ULA ( Figure 2E (Figure 7C) . Combined, these data suggest that ID1 and ID3 might be 360 involved in the disease progression of patients with ILC, which warrants further investigation. Interestingly, a recent study using human IDC cell lines reported a strong correlation between the 402 ability to grow in ULA and to form colonies in soft agar [52] . These data further highlight the 
